← Leaderboards
Michael S Rafii
University Of California, San Diego
$15,654,843
Attributed
$19,216,238
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,315,877 · 7
By mechanism
R33$6,863,895 · 1
R61$5,646,672 · 1
R01$4,126,881 · 3
RF1$2,578,790 · 1
U19$99,639 · 1
Top collaborators
- Robert A Rissman4 shared
- Paul S. Aisen1 shared
- Olga Brawman-Mintzer1 shared
- Jacobo E. Mintzer1 shared
- William C Mobley1 shared
- Brigid Reynolds1 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Howard Feldman$27,033,634
- Danielle E Ramo$1,957,167
- Michael Hogarth$15,482,385
- Robin Knight$23,265,798
- William C Mobley$20,695,689
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseClinical TrialsImpaired CognitionDementiaPlasmaBiological MarkersPreventAdultTau ProteinsAmyloid Beta-ProteinDisease ProgressionDown SyndromeTherapeutic TrialsInfrastructureAlzheimerâS Disease BiomarkerEnrollmentFundingIntellectual Functioning DisabilityExhibitsFutureProceduresGeneticAmyloid
Grant awards (13)
Lifeâs end Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY) Open-Label Extension (OLE) Study$2,072,617
R01 · FY2025 · AG
Precision Medicine for Inflammatory Treatment for Alzheimer's Disease in Down Syndrome$604,405
R01 · FY2025 · AG
Clinical trials to prevent Alzheimer's Disease in Down Syndrome$2,284,142
R33 · FY2024 · AG · contact PI
Precision Medicine for Inflammatory Treatment for Alzheimer's Disease in Down Syndrome$623,408
R01 · FY2024 · AG
Clinical trials to prevent Alzheimer's Disease in Down Syndrome$2,287,306
R33 · FY2023 · AG · contact PI
Clinical trials to prevent Alzheimer's Disease in Down Syndrome$2,292,447
R33 · FY2022 · AG · contact PI
Precision Medicine for Inflammatory Treatment for Alzheimer's Disease in Down Syndrome$249,999
RF1 · FY2022 · AG
Precision Medicine for Inflammatory Treatment for Alzheimer's Disease in Down Syndrome$2,328,791
RF1 · FY2021 · AG
Clinical trials to prevent Alzheimer's Disease in Down Syndrome$2,324,837
R61 · FY2020 · AG · contact PI
Clinical trials to prevent Alzheimer's Disease in Down Syndrome$998,408
R61 · FY2020 · AG · contact PI
Clinical trials to prevent Alzheimer's Disease in Down Syndrome$2,323,427
R61 · FY2019 · AG · contact PI
Alzheimer's Disease Cooperative Study$99,639
U19 · FY2015 · AG
ACTIVE IMMUNOTHERAPY FOR COGNITIVE DECLINE IN ADULTS WITH DOWN SYNDROME$826,451
R01 · FY2014 · AG · contact PI